Literature DB >> 7743629

Selective impairment of vagally mediated, nitric oxide-dependent coronary vasodilation in conscious dogs after pacing-induced heart failure.

G Zhao1, W Shen, X Xu, M Ochoa, R Bernstein, T H Hintze.   

Abstract

BACKGROUND: Activation in conscious dogs of the carotid chemoreflex or cardiac receptors results in coronary vasodilation that is mediated by a vagal cholinergic mechanism. Our previous study showed that the coronary vasodilation following activation of carotid chemoreflex is also mediated by nitric oxide (NO). In addition, NO production is depressed after the development of heart failure. Therefore, we hypothesized that the coronary vasodilation after activation of reflexes that elicit efferent vagal coronary vasodilation would be blunted in conscious dogs after pacing-induced heart failure due to the disappearance of NO. METHODS AND
RESULTS: Mongrel dogs were chronically instrumented using sterile techniques for measurements of systemic hemodynamics and left circumflex coronary blood flow (CBF). Without the heart rate controlled, intra-atrial injection of veratrine (4 micrograms/kg) caused bradycardia (-36 +/- 3 beats per minute). With the heart rate controlled, veratrine increased CBF in a dose-dependent manner: for example, 4 micrograms/kg of veratrine increased CBF by 54 +/- 5% from 38 +/- 4.9 mL/min (P < .05). The increases in CBF induced by veratrine were markedly blunted by nitro-L-arginine (NLA). Activation of carotid chemoreflex by nicotine increased CBF by 121 +/- 9% from 32 +/- 4 mL++/min (P < .05) with the heart rate controlled and caused bradycardia (-32 +/- 5 beats per minute) without the heart rate controlled. After the development of heart failure, in response to activation of carotid chemoreflex or cardiac receptors the coronary vasodilation was almost abolished (CBF increased by only 23 +/- 8% or 11 +/- 3%, P < .05 compared with control). There still was a marked bradycardia after injections of nicotine or veratrine (-50 +/- 11 or -48 +/- 7 beats per minute).
CONCLUSIONS: Our results indicate that vagally mediated coronary vasodilation is selectively attenuated in conscious dogs after pacing-induced heart failure, whereas the vagally mediated bradycardia is preserved. Since muscarinic receptor-induced coronary vasodilation is mediated by NO, the disappearance of NO from blood vessels leads to a defect in the integrated neural regulation of coronary blood flow and myocardial function during heart failure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743629     DOI: 10.1161/01.cir.91.10.2655

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

Review 1.  Cardiac Innervation and the Autonomic Nervous System in Sudden Cardiac Death.

Authors:  William A Huang; Noel G Boyle; Marmar Vaseghi
Journal:  Card Electrophysiol Clin       Date:  2017-12

2.  Device-based autonomic modulation in arrhythmia patients: the role of vagal nerve stimulation.

Authors:  William A Huang; Kalyanam Shivkumar; Marmar Vaseghi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-05

3.  Heart failure and statins--why do we need a clinical trial?

Authors:  M Böhm; A Hjalmarson; J Kjekshus; U Laufs; J McMurray; D J van Veldhuisen
Journal:  Z Kardiol       Date:  2005-04

4.  SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells.

Authors:  Lahouaria Hadri; Regis Bobe; Yoshiaki Kawase; Dennis Ladage; Kiyotake Ishikawa; Fabrice Atassi; Djamel Lebeche; Evangelia G Kranias; Jane A Leopold; Anne-Marie Lompré; Larissa Lipskaia; Roger J Hajjar
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

5.  Reduced coronary vasodilator responses to amlodipine in pacing-induced heart failure in conscious dogs: role of nitric oxide.

Authors:  Stéphane Champagne; Luc Hittinger; François Héloire; Yukio Suto; Lucien Sambin; Bertrand Crozatier; Jin Bo Su
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

6.  Potential mechanisms of low-sodium diet-induced cardiac disease: superoxide-NO in the heart.

Authors:  Nobuhiro Suematsu; Caroline Ojaimi; Fabio A Recchia; Zipping Wang; Yester Skayian; Xiaobin Xu; Suhua Zhang; Pawel M Kaminski; Dong Sun; Michael S Wolin; Gabor Kaley; Thomas H Hintze
Journal:  Circ Res       Date:  2009-12-10       Impact factor: 17.367

7.  Reduced left ventricular compliance and mechanical efficiency after prolonged inhibition of NO synthesis in conscious dogs.

Authors:  Heiner Post; Chiara d'Agostino; Vincenzo Lionetti; Michele Castellari; Elaine Y Kang; Martin Altarejos; Xiaobin Xu; Thomas H Hintze; Fabio A Recchia
Journal:  J Physiol       Date:  2003-07-23       Impact factor: 5.182

8.  Preservation of NO production by statins in the treatment of heart failure.

Authors:  Jean-Noel Trochu; Seema Mital; Xiao ping Zhang; Xiaobin Xu; Manuel Ochoa; James K Liao; Fabio A Recchia; Thomas H Hintze
Journal:  Cardiovasc Res       Date:  2003-11-01       Impact factor: 10.787

Review 9.  Acute and chronic endothelial dysfunction: implications for the development of heart failure.

Authors:  Axel Linke; Fabio Recchia; Xiaoping Zhang; Thomas H Hintze
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

10.  Chemogenetic activation of intracardiac cholinergic neurons improves cardiac function in pressure overload-induced heart failure.

Authors:  Jhansi Dyavanapalli; Aloysius James Hora; Joan B Escobar; John Schloen; Mary Kate Dwyer; Jeannette Rodriguez; Christopher F Spurney; Matthew W Kay; David Mendelowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.